Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 423

1.

Targeting ferroptosis in rhabdomyosarcoma cells.

Dächert J, Ehrenfeld V, Habermann K, Dolgikh N, Fulda S.

Int J Cancer. 2019 Jun 7. doi: 10.1002/ijc.32496. [Epub ahead of print]

PMID:
31173656
2.

Smac mimetic suppresses tunicamycin-induced apoptosis via resolution of ER stress.

Abhari BA, McCarthy N, Le Berre M, Kilcoyne M, Joshi L, Agostinis P, Fulda S.

Cell Death Dis. 2019 Feb 15;10(3):155. doi: 10.1038/s41419-019-1381-z.

3.

Cell cycle arrest in mitosis promotes interferon-induced necroptosis.

Frank T, Tuppi M, Hugle M, Dötsch V, van Wijk SJL, Fulda S.

Cell Death Differ. 2019 Feb 11. doi: 10.1038/s41418-019-0298-5. [Epub ahead of print]

PMID:
30742091
4.

NF-κB contributes to Smac mimetic-conferred protection from tunicamycin-induced apoptosis.

Abhari BA, McCarthy N, Agostinis P, Fulda S.

Apoptosis. 2019 Apr;24(3-4):269-277. doi: 10.1007/s10495-018-1507-2.

PMID:
30680482
5.

Visualizing ubiquitination in mammalian cells.

van Wijk SJ, Fulda S, Dikic I, Heilemann M.

EMBO Rep. 2019 Feb;20(2). pii: e46520. doi: 10.15252/embr.201846520. Epub 2019 Jan 21. Review.

PMID:
30665942
6.

Cotreatment with sorafenib and oleanolic acid induces reactive oxygen species-dependent and mitochondrial-mediated apoptotic cell death in hepatocellular carcinoma cells.

Liese J, Hinrichs TM, Lange M, Fulda S.

Anticancer Drugs. 2019 Mar;30(3):209-217. doi: 10.1097/CAD.0000000000000750.

PMID:
30640794
7.

Effect of mirtazapine on metabolism and energy substrate partitioning in healthy men.

Hennings JM, Heel S, Lechner K, Uhr M, Dose T, Schaaf L, Holsboer F, Lucae S, Fulda S, Kloiber S.

JCI Insight. 2019 Jan 10;4(1). pii: 123786. doi: 10.1172/jci.insight.123786. [Epub ahead of print]

8.

Interferons Transcriptionally Up-Regulate MLKL Expression in Cancer Cells.

Knuth AK, Rösler S, Schenk B, Kowald L, van Wijk SJL, Fulda S.

Neoplasia. 2019 Jan;21(1):74-81. doi: 10.1016/j.neo.2018.11.002. Epub 2018 Dec 3.

9.

Loss of the Chr16p11.2 ASD candidate gene QPRT leads to aberrant neuronal differentiation in the SH-SY5Y neuronal cell model.

Haslinger D, Waltes R, Yousaf A, Lindlar S, Schneider I, Lim CK, Tsai MM, Garvalov BK, Acker-Palmer A, Krezdorn N, Rotter B, Acker T, Guillemin GJ, Fulda S, Freitag CM, Chiocchetti AG.

Mol Autism. 2018 Nov 6;9:56. doi: 10.1186/s13229-018-0239-z. eCollection 2018.

10.

Differential involvement of TAK1, RIPK1 and NF-κB signaling in Smac mimetic-induced cell death in breast cancer cells.

Schmidt N, Kowald L, van Wijk SJL, Fulda S.

Biol Chem. 2019 Jan 28;400(2):171-180. doi: 10.1515/hsz-2018-0324.

PMID:
30391931
11.

Different Response of Ptch Mutant and Ptch Wildtype Rhabdomyosarcoma Toward SMO and PI3K Inhibitors.

Geyer N, Ridzewski R, Bauer J, Kuzyakova M, Dittmann K, Dullin C, Rosenberger A, Schildhaus HU, Uhmann A, Fulda S, Hahn H.

Front Oncol. 2018 Sep 25;8:396. doi: 10.3389/fonc.2018.00396. eCollection 2018.

12.

Identification of Smac mimetics as novel substrates for p-glycoprotein.

Hugle M, Czaplinski S, Habermann K, Vogler M, Fulda S.

Cancer Lett. 2019 Jan;440-441:126-134. doi: 10.1016/j.canlet.2018.10.001. Epub 2018 Oct 9.

PMID:
30312727
13.

Loperamide, pimozide, and STF-62247 trigger autophagy-dependent cell death in glioblastoma cells.

Zielke S, Meyer N, Mari M, Abou-El-Ardat K, Reggiori F, van Wijk SJL, Kögel D, Fulda S.

Cell Death Dis. 2018 Sep 24;9(10):994. doi: 10.1038/s41419-018-1003-1.

14.

Endoplasmic reticulum stress signalling - from basic mechanisms to clinical applications.

Almanza A, Carlesso A, Chintha C, Creedican S, Doultsinos D, Leuzzi B, Luís A, McCarthy N, Montibeller L, More S, Papaioannou A, Püschel F, Sassano ML, Skoko J, Agostinis P, de Belleroche J, Eriksson LA, Fulda S, Gorman AM, Healy S, Kozlov A, Muñoz-Pinedo C, Rehm M, Chevet E, Samali A.

FEBS J. 2019 Jan;286(2):241-278. doi: 10.1111/febs.14608. Epub 2018 Aug 4. Review.

15.

Nano-targeted induction of dual ferroptotic mechanisms eradicates high-risk neuroblastoma.

Hassannia B, Wiernicki B, Ingold I, Qu F, Van Herck S, Tyurina YY, Bayır H, Abhari BA, Angeli JPF, Choi SM, Meul E, Heyninck K, Declerck K, Chirumamilla CS, Lahtela-Kakkonen M, Van Camp G, Krysko DV, Ekert PG, Fulda S, De Geest BG, Conrad M, Kagan VE, Vanden Berghe W, Vandenabeele P, Vanden Berghe T.

J Clin Invest. 2018 Aug 1;128(8):3341-3355. doi: 10.1172/JCI99032. Epub 2018 Jun 25.

16.

AT 101 induces early mitochondrial dysfunction and HMOX1 (heme oxygenase 1) to trigger mitophagic cell death in glioma cells.

Meyer N, Zielke S, Michaelis JB, Linder B, Warnsmann V, Rakel S, Osiewacz HD, Fulda S, Mittelbronn M, Münch C, Behrends C, Kögel D.

Autophagy. 2018;14(10):1693-1709. doi: 10.1080/15548627.2018.1476812. Epub 2018 Jul 21.

PMID:
29938581
17.

Selective BH3-mimetics targeting BCL-2, BCL-XL or MCL-1 induce severe mitochondrial perturbations.

Henz K, Al-Zebeeby A, Basoglu M, Fulda S, Cohen GM, Varadarajan S, Vogler M.

Biol Chem. 2019 Jan 28;400(2):181-185. doi: 10.1515/hsz-2018-0233.

PMID:
29924730
18.

Author Correction: The landscape of genomic alterations across childhood cancers.

Gröbner SN, Worst BC, Weischenfeldt J, Buchhalter I, Kleinheinz K, Rudneva VA, Johann PD, Balasubramanian GP, Segura-Wang M, Brabetz S, Bender S, Hutter B, Sturm D, Pfaff E, Hübschmann D, Zipprich G, Heinold M, Eils J, Lawerenz C, Erkek S, Lambo S, Waszak S, Blattmann C, Borkhardt A, Kuhlen M, Eggert A, Fulda S, Gessler M, Wegert J, Kappler R, Baumhoer D, Burdach S, Kirschner-Schwabe R, Kontny U, Kulozik AE, Lohmann D, Hettmer S, Eckert C, Bielack S, Nathrath M, Niemeyer C, Richter GH, Schulte J, Siebert R, Westermann F, Molenaar JJ, Vassal G, Witt H, Burkhardt B, Kratz CP, Witt O, van Tilburg CM, Kramm CM, Fleischhack G, Dirksen U, Rutkowski S, Frühwald M, von Hoff K, Wolf S, Klingebiel T, Koscielniak E, Landgraf P, Koster J, Resnick AC, Zhang J, Liu Y, Zhou X, Waanders AJ, Zwijnenburg DA, Raman P, Brors B, Weber UD, Northcott PA, Pajtler KW, Kool M, Piro RM, Korbel JO, Schlesner M, Eils R, Jones DTW, Lichter P, Chavez L, Zapatka M, Pfister SM; ICGC PedBrain-Seq Project; ICGC MMML-Seq Project.

Nature. 2018 Jul;559(7714):E10. doi: 10.1038/s41586-018-0167-2.

PMID:
29875405
19.

BCL-2 selective inhibitor ABT-199 primes rhabdomyosarcoma cells to histone deacetylase inhibitor-induced apoptosis.

Heinicke U, Haydn T, Kehr S, Vogler M, Fulda S.

Oncogene. 2018 Sep;37(39):5325-5339. doi: 10.1038/s41388-018-0212-5. Epub 2018 Jun 1.

PMID:
29858601
20.

Biglycan is a new high-affinity ligand for CD14 in macrophages.

Roedig H, Nastase MV, Frey H, Moreth K, Zeng-Brouwers J, Poluzzi C, Hsieh LT, Brandts C, Fulda S, Wygrecka M, Schaefer L.

Matrix Biol. 2019 Apr;77:4-22. doi: 10.1016/j.matbio.2018.05.006. Epub 2018 May 17.

PMID:
29777767
21.

Co-targeting of BET proteins and HDACs as a novel approach to trigger apoptosis in rhabdomyosarcoma cells.

Enßle JC, Boedicker C, Wanior M, Vogler M, Knapp S, Fulda S.

Cancer Lett. 2018 Aug 1;428:160-172. doi: 10.1016/j.canlet.2018.04.032. Epub 2018 Apr 27.

PMID:
29709701
22.

Hedgehog signaling negatively co-regulates BH3-only protein Noxa and TAp73 in TP53-mutated cells.

Meister MT, Boedicker C, Klingebiel T, Fulda S.

Cancer Lett. 2018 Aug 10;429:19-28. doi: 10.1016/j.canlet.2018.04.025. Epub 2018 Apr 24.

PMID:
29702195
23.

Regulation of the antiapoptotic protein cFLIP by the glucocorticoid Dexamethasone in ALL cells.

Kleinesudeik L, Rohde K, Fulda S.

Oncotarget. 2018 Mar 27;9(23):16521-16532. doi: 10.18632/oncotarget.24782. eCollection 2018 Mar 27.

24.

Targeting autophagy for the treatment of cancer.

Fulda S.

Biol Chem. 2018 Jun 27;399(7):673-677. doi: 10.1515/hsz-2018-0105.

PMID:
29500917
25.

The landscape of genomic alterations across childhood cancers.

Gröbner SN, Worst BC, Weischenfeldt J, Buchhalter I, Kleinheinz K, Rudneva VA, Johann PD, Balasubramanian GP, Segura-Wang M, Brabetz S, Bender S, Hutter B, Sturm D, Pfaff E, Hübschmann D, Zipprich G, Heinold M, Eils J, Lawerenz C, Erkek S, Lambo S, Waszak S, Blattmann C, Borkhardt A, Kuhlen M, Eggert A, Fulda S, Gessler M, Wegert J, Kappler R, Baumhoer D, Burdach S, Kirschner-Schwabe R, Kontny U, Kulozik AE, Lohmann D, Hettmer S, Eckert C, Bielack S, Nathrath M, Niemeyer C, Richter GH, Schulte J, Siebert R, Westermann F, Molenaar JJ, Vassal G, Witt H; ICGC PedBrain-Seq Project; ICGC MMML-Seq Project, Burkhardt B, Kratz CP, Witt O, van Tilburg CM, Kramm CM, Fleischhack G, Dirksen U, Rutkowski S, Frühwald M, von Hoff K, Wolf S, Klingebiel T, Koscielniak E, Landgraf P, Koster J, Resnick AC, Zhang J, Liu Y, Zhou X, Waanders AJ, Zwijnenburg DA, Raman P, Brors B, Weber UD, Northcott PA, Pajtler KW, Kool M, Piro RM, Korbel JO, Schlesner M, Eils R, Jones DTW, Lichter P, Chavez L, Zapatka M, Pfister SM.

Nature. 2018 Mar 15;555(7696):321-327. doi: 10.1038/nature25480. Epub 2018 Feb 28. Erratum in: Nature. 2018 Jul;559(7714):E10.

PMID:
29489754
26.

Repurposing anticancer drugs for targeting necroptosis.

Fulda S.

Cell Cycle. 2018;17(7):829-832. doi: 10.1080/15384101.2018.1442626. Epub 2018 Apr 25.

27.

NRAS-Mutated Rhabdomyosarcoma Cells Are Vulnerable to Mitochondrial Apoptosis Induced by Coinhibition of MEK and PI3Kα.

Dolgikh N, Hugle M, Vogler M, Fulda S.

Cancer Res. 2018 Apr 15;78(8):2000-2013. doi: 10.1158/0008-5472.CAN-17-1737. Epub 2018 Feb 6.

28.

Smac mimetic induces an early wave of gene expression via NF-κB and AP-1 and a second wave via TNFR1 signaling.

Schmidt N, Haydn T, Schneider I, Busch H, Boerries M, Fulda S.

Cancer Lett. 2018 May 1;421:170-185. doi: 10.1016/j.canlet.2018.01.082. Epub 2018 Feb 5.

PMID:
29421152
29.

Cell death-based treatment of glioblastoma.

Fulda S.

Cell Death Dis. 2018 Jan 25;9(2):121. doi: 10.1038/s41419-017-0021-8. Review.

30.

Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018.

Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, Alnemri ES, Altucci L, Amelio I, Andrews DW, Annicchiarico-Petruzzelli M, Antonov AV, Arama E, Baehrecke EH, Barlev NA, Bazan NG, Bernassola F, Bertrand MJM, Bianchi K, Blagosklonny MV, Blomgren K, Borner C, Boya P, Brenner C, Campanella M, Candi E, Carmona-Gutierrez D, Cecconi F, Chan FK, Chandel NS, Cheng EH, Chipuk JE, Cidlowski JA, Ciechanover A, Cohen GM, Conrad M, Cubillos-Ruiz JR, Czabotar PE, D'Angiolella V, Dawson TM, Dawson VL, De Laurenzi V, De Maria R, Debatin KM, DeBerardinis RJ, Deshmukh M, Di Daniele N, Di Virgilio F, Dixit VM, Dixon SJ, Duckett CS, Dynlacht BD, El-Deiry WS, Elrod JW, Fimia GM, Fulda S, García-Sáez AJ, Garg AD, Garrido C, Gavathiotis E, Golstein P, Gottlieb E, Green DR, Greene LA, Gronemeyer H, Gross A, Hajnoczky G, Hardwick JM, Harris IS, Hengartner MO, Hetz C, Ichijo H, Jäättelä M, Joseph B, Jost PJ, Juin PP, Kaiser WJ, Karin M, Kaufmann T, Kepp O, Kimchi A, Kitsis RN, Klionsky DJ, Knight RA, Kumar S, Lee SW, Lemasters JJ, Levine B, Linkermann A, Lipton SA, Lockshin RA, López-Otín C, Lowe SW, Luedde T, Lugli E, MacFarlane M, Madeo F, Malewicz M, Malorni W, Manic G, Marine JC, Martin SJ, Martinou JC, Medema JP, Mehlen P, Meier P, Melino S, Miao EA, Molkentin JD, Moll UM, Muñoz-Pinedo C, Nagata S, Nuñez G, Oberst A, Oren M, Overholtzer M, Pagano M, Panaretakis T, Pasparakis M, Penninger JM, Pereira DM, Pervaiz S, Peter ME, Piacentini M, Pinton P, Prehn JHM, Puthalakath H, Rabinovich GA, Rehm M, Rizzuto R, Rodrigues CMP, Rubinsztein DC, Rudel T, Ryan KM, Sayan E, Scorrano L, Shao F, Shi Y, Silke J, Simon HU, Sistigu A, Stockwell BR, Strasser A, Szabadkai G, Tait SWG, Tang D, Tavernarakis N, Thorburn A, Tsujimoto Y, Turk B, Vanden Berghe T, Vandenabeele P, Vander Heiden MG, Villunger A, Virgin HW, Vousden KH, Vucic D, Wagner EF, Walczak H, Wallach D, Wang Y, Wells JA, Wood W, Yuan J, Zakeri Z, Zhivotovsky B, Zitvogel L, Melino G, Kroemer G.

Cell Death Differ. 2018 Mar;25(3):486-541. doi: 10.1038/s41418-017-0012-4. Epub 2018 Jan 23. Review.

31.

Mouse lung fibroblasts are highly susceptible to necroptosis in a reactive oxygen species-dependent manner.

Hussain M, Zimmermann V, van Wijk SJL, Fulda S.

Biochem Pharmacol. 2018 Jul;153:242-247. doi: 10.1016/j.bcp.2018.01.025. Epub 2018 Jan 11.

PMID:
29337003
32.

Characteristics and determinants of respiratory event associated leg movements.

Fulda S, Heinzer R, Haba-Rubio J.

Sleep. 2017 Dec 15. doi: 10.1093/sleep/zsx206. [Epub ahead of print]

PMID:
29253240
33.

Structure-activity studies on N-Substituted tranylcypromine derivatives lead to selective inhibitors of lysine specific demethylase 1 (LSD1) and potent inducers of leukemic cell differentiation.

Schulz-Fincke J, Hau M, Barth J, Robaa D, Willmann D, Kürner A, Haas J, Greve G, Haydn T, Fulda S, Lübbert M, Lüdeke S, Berg T, Sippl W, Schüle R, Jung M.

Eur J Med Chem. 2018 Jan 20;144:52-67. doi: 10.1016/j.ejmech.2017.12.001. Epub 2017 Dec 6.

PMID:
29247860
34.

Therapeutic opportunities based on caspase modulation.

Fulda S.

Semin Cell Dev Biol. 2018 Oct;82:150-157. doi: 10.1016/j.semcdb.2017.12.008. Epub 2017 Dec 15. Review.

PMID:
29247787
35.

Congenital embryonal rhabdomyosarcoma caused by heterozygous concomitant PTCH1 and PTCH2 germline mutations.

Taeubner J, Brozou T, Qin N, Bartl J, Ginzel S, Schaper J, Felsberg J, Fulda S, Vokuhl C, Borkhardt A, Kuhlen M.

Eur J Hum Genet. 2018 Jan;26(1):137-142. doi: 10.1038/s41431-017-0048-4. Epub 2017 Dec 11.

36.

Rhabdomyosarcoma cells are susceptible to cell death by LDK378 alone or in combination with sorafenib independently of anaplastic lymphoma kinase status.

Dolgikh N, Fulda S.

Anticancer Drugs. 2017 Nov;28(10):1118-1125. doi: 10.1097/CAD.0000000000000552.

PMID:
29045271
37.

Generation and characterization of ErbB2-CAR-engineered cytokine-induced killer cells for the treatment of high-risk soft tissue sarcoma in children.

Merker M, Pfirrmann V, Oelsner S, Fulda S, Klingebiel T, Wels WS, Bader P, Rettinger E.

Oncotarget. 2017 Aug 2;8(39):66137-66153. doi: 10.18632/oncotarget.19821. eCollection 2017 Sep 12.

38.

Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease.

Stockwell BR, Friedmann Angeli JP, Bayir H, Bush AI, Conrad M, Dixon SJ, Fulda S, Gascón S, Hatzios SK, Kagan VE, Noel K, Jiang X, Linkermann A, Murphy ME, Overholtzer M, Oyagi A, Pagnussat GC, Park J, Ran Q, Rosenfeld CS, Salnikow K, Tang D, Torti FM, Torti SV, Toyokuni S, Woerpel KA, Zhang DD.

Cell. 2017 Oct 5;171(2):273-285. doi: 10.1016/j.cell.2017.09.021. Review.

39.

Targeting redox homeostasis in rhabdomyosarcoma cells: GSH-depleting agents enhance auranofin-induced cell death.

Habermann KJ, Grünewald L, van Wijk S, Fulda S.

Cell Death Dis. 2017 Oct 5;8(10):e3067. doi: 10.1038/cddis.2017.412.

40.

Sorafenib inhibits therapeutic induction of necroptosis in acute leukemia cells.

Feldmann F, Schenk B, Martens S, Vandenabeele P, Fulda S.

Oncotarget. 2017 Aug 4;8(40):68208-68220. doi: 10.18632/oncotarget.19919. eCollection 2017 Sep 15.

41.

BCL-xL-selective BH3 mimetic sensitizes rhabdomyosarcoma cells to chemotherapeutics by activation of the mitochondrial pathway of apoptosis.

Faqar-Uz-Zaman SF, Heinicke U, Meister MT, Vogler M, Fulda S.

Cancer Lett. 2018 Jan 1;412:131-142. doi: 10.1016/j.canlet.2017.09.025. Epub 2017 Sep 23.

PMID:
28947136
42.

Smac mimetics and type II interferon synergistically induce necroptosis in various cancer cell lines.

Cekay MJ, Roesler S, Frank T, Knuth AK, Eckhardt I, Fulda S.

Cancer Lett. 2017 Dec 1;410:228-237. doi: 10.1016/j.canlet.2017.09.002. Epub 2017 Sep 18.

PMID:
28923396
43.

Eribulin alone or in combination with the PLK1 inhibitor BI 6727 triggers intrinsic apoptosis in Ewing sarcoma cell lines.

WeiΔ LM, Hugle M, Fulda S.

Oncotarget. 2017 Apr 18;8(32):52445-52456. doi: 10.18632/oncotarget.17190. eCollection 2017 Aug 8.

44.

Manatee invariants reveal functional pathways in signaling networks.

Amstein L, Ackermann J, Scheidel J, Fulda S, Dikic I, Koch I.

BMC Syst Biol. 2017 Jul 28;11(1):72. doi: 10.1186/s12918-017-0448-7.

45.

Identification of a synergistic combination of Smac mimetic and Bortezomib to trigger cell death in B-cell non-Hodgkin lymphoma cells.

Bhatti IA, Abhari BA, Fulda S.

Cancer Lett. 2017 Oct 1;405:63-72. doi: 10.1016/j.canlet.2017.07.008. Epub 2017 Jul 14.

PMID:
28716527
46.

Autophagy in Cancer Therapy.

Fulda S.

Front Oncol. 2017 Jun 15;7:128. doi: 10.3389/fonc.2017.00128. eCollection 2017. Review.

47.

Sorafenib tosylate inhibits directly necrosome complex formation and protects in mouse models of inflammation and tissue injury.

Martens S, Jeong M, Tonnus W, Feldmann F, Hofmans S, Goossens V, Takahashi N, Bräsen JH, Lee EW, Van der Veken P, Joossens J, Augustyns K, Fulda S, Linkermann A, Song J, Vandenabeele P.

Cell Death Dis. 2017 Jun 29;8(6):e2904. doi: 10.1038/cddis.2017.298.

48.

Concomitant epigenetic targeting of LSD1 and HDAC synergistically induces mitochondrial apoptosis in rhabdomyosarcoma cells.

Haydn T, Metzger E, Schuele R, Fulda S.

Cell Death Dis. 2017 Jun 15;8(6):e2879. doi: 10.1038/cddis.2017.239.

49.

Molecular definitions of autophagy and related processes.

Galluzzi L, Baehrecke EH, Ballabio A, Boya P, Bravo-San Pedro JM, Cecconi F, Choi AM, Chu CT, Codogno P, Colombo MI, Cuervo AM, Debnath J, Deretic V, Dikic I, Eskelinen EL, Fimia GM, Fulda S, Gewirtz DA, Green DR, Hansen M, Harper JW, Jäättelä M, Johansen T, Juhasz G, Kimmelman AC, Kraft C, Ktistakis NT, Kumar S, Levine B, Lopez-Otin C, Madeo F, Martens S, Martinez J, Melendez A, Mizushima N, Münz C, Murphy LO, Penninger JM, Piacentini M, Reggiori F, Rubinsztein DC, Ryan KM, Santambrogio L, Scorrano L, Simon AK, Simon HU, Simonsen A, Tavernarakis N, Tooze SA, Yoshimori T, Yuan J, Yue Z, Zhong Q, Kroemer G.

EMBO J. 2017 Jul 3;36(13):1811-1836. doi: 10.15252/embj.201796697. Epub 2017 Jun 8. Review.

50.

Lipoxygenase inhibitors protect acute lymphoblastic leukemia cells from ferroptotic cell death.

Probst L, Dächert J, Schenk B, Fulda S.

Biochem Pharmacol. 2017 Sep 15;140:41-52. doi: 10.1016/j.bcp.2017.06.112. Epub 2017 Jun 6.

PMID:
28595877

Supplemental Content

Support Center